
EDAP TMS S.A. EDAP
€ 3.46
0.37%
Quartalsbericht 2024-Q4
hinzugefügt 31.01.2026
EDAP TMS S.A. Kurzfristige Verbindlichkeiten 2011-2026 | EDAP
Kurzfristige Verbindlichkeiten Jährlich EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.8 M | 27.6 M | 21.7 M | 18 M | 21.5 M | 17.5 M | 16.8 M | 16.1 M | 15 M | 16.3 M | 12.2 M | 11.6 M | 13.1 M | 19.7 M |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 37.8 M | 11.6 M | 18.9 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
219 M | $ 7.25 | -8.17 % | $ 521 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Aziyo Biologics
AZYO
|
43 M | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
12.7 M | $ 3.97 | - | $ 137 M | ||
|
Alphatec Holdings
ATEC
|
153 M | $ 13.48 | -4.13 % | $ 1.93 B | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Bio-Rad Laboratories
BIO
|
468 M | $ 299.07 | -2.23 % | $ 8.44 B | ||
|
Bruker Corporation
BRKR
|
1.28 B | $ 41.06 | -3.54 % | $ 6.12 K | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
6.4 B | $ 78.26 | 3.65 % | $ 115 B | ||
|
Abbott Laboratories
ABT
|
14.2 B | $ 109.11 | 0.84 % | $ 190 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
ClearPoint Neuro
CLPT
|
10.4 M | $ 12.43 | -6.61 % | $ 336 M | ||
|
CONMED Corporation
CNMD
|
278 M | $ 40.63 | 1.75 % | $ 1.25 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
10.5 M | $ 28.95 | -0.96 % | $ 245 M | ||
|
InMode Ltd.
INMD
|
69.9 M | $ 14.77 | -1.66 % | $ 1.17 B | ||
|
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
2.04 B | $ 176.77 | 9.59 % | $ 13.2 B | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
16.7 M | $ 18.54 | 0.11 % | $ 122 M | ||
|
Globus Medical
GMED
|
856 M | $ 87.55 | 0.56 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 10.94 | -1.26 % | $ 842 M | ||
|
Establishment Labs Holdings
ESTA
|
68.3 M | $ 66.7 | -3.52 % | $ 1.88 B | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 1.45 | 0.69 % | $ 23.4 M | ||
|
IRadimed Corporation
IRMD
|
8.51 M | $ 94.23 | 0.4 % | $ 1.19 B | ||
|
Integer Holdings Corporation
ITGR
|
227 M | $ 85.94 | 0.49 % | $ 2.89 B | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.67 | 0.3 % | $ 36.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
34 M | $ 16.64 | -1.54 % | $ 384 M |